Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria
Phase of Trial: Phase IV
Latest Information Update: 16 Aug 2017
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Antithymocyte globulin; Mycophenolate sodium; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- 11 Aug 2017 Status changed from active, no longer recruiting to completed.
- 15 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 15 Aug 2016 Status changed from recruiting to active, no longer recruiting.